Key factors involved in the feeding and eating disorders among schizophrenic patients and non-clinical controls

IF 0.3 Q4 PSYCHIATRY
M. Khosravi
{"title":"Key factors involved in the feeding and eating disorders among schizophrenic patients and non-clinical controls","authors":"M. Khosravi","doi":"10.12740/app/127307","DOIUrl":null,"url":null,"abstract":"Factors associated with comorbidity of schizophrenia and feeding and eating disorders (FEDs) need to be precisely investigated due to their endocrine and cardiometabolic complications. Therefore, the present study was performed aiming to examine the prevalence of FEDs and its involved key factors among schizophrenic patients and non-clinical controlsIn this cross-sectional correlational study, a total of 268 Iranian participants (including 134 schizophrenic patients and 134 non-clinical controls) were selected through the convenient sampling method from people living in Zahedan, Iran. They were assessed using demographic information form, Eating Attitudes Test-26 Item (EAT-26), and Structured Clinical Interviews for DSM-5: Research Version.The findings of this study showed that almost one third of schizophrenic patients had FEDs that this prevalence was about 2.5 times that in non-clinical controls (32.1% vs. 12.7%, p<0.001). in schizophrenic patients, the results of regression analysis also revealed that higher scores of EAT-26 were associated with higher levels of anxiety, depression, and body mass index (BMI), Type 2 diabetes, tobacco smoking, earlier stages of disease, more severe psychotic symptoms, and taking atypical antipsychotics (R2=0.93, p˂0.001). Contrarily, no relationship was observed between the EAT-26 scores and both gender and different phases of schizophrenia.Clinicians need to assess the risk of FEDs during the entire course of schizophrenia, particularly in its earlier stages.It is necessary to address the role of key factors, such as anxiety, depression, BMI, Type 2 diabetes, tobacco smoking, severity of psychosis, category of antipsychotic medications in the modeling of eating pathology among schizophrenic patients.","PeriodicalId":44856,"journal":{"name":"Archives of Psychiatry and Psychotherapy","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2021-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Psychiatry and Psychotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12740/app/127307","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 2

Abstract

Factors associated with comorbidity of schizophrenia and feeding and eating disorders (FEDs) need to be precisely investigated due to their endocrine and cardiometabolic complications. Therefore, the present study was performed aiming to examine the prevalence of FEDs and its involved key factors among schizophrenic patients and non-clinical controlsIn this cross-sectional correlational study, a total of 268 Iranian participants (including 134 schizophrenic patients and 134 non-clinical controls) were selected through the convenient sampling method from people living in Zahedan, Iran. They were assessed using demographic information form, Eating Attitudes Test-26 Item (EAT-26), and Structured Clinical Interviews for DSM-5: Research Version.The findings of this study showed that almost one third of schizophrenic patients had FEDs that this prevalence was about 2.5 times that in non-clinical controls (32.1% vs. 12.7%, p<0.001). in schizophrenic patients, the results of regression analysis also revealed that higher scores of EAT-26 were associated with higher levels of anxiety, depression, and body mass index (BMI), Type 2 diabetes, tobacco smoking, earlier stages of disease, more severe psychotic symptoms, and taking atypical antipsychotics (R2=0.93, p˂0.001). Contrarily, no relationship was observed between the EAT-26 scores and both gender and different phases of schizophrenia.Clinicians need to assess the risk of FEDs during the entire course of schizophrenia, particularly in its earlier stages.It is necessary to address the role of key factors, such as anxiety, depression, BMI, Type 2 diabetes, tobacco smoking, severity of psychosis, category of antipsychotic medications in the modeling of eating pathology among schizophrenic patients.
精神分裂症患者及非临床对照中进食障碍的关键因素
精神分裂症和进食障碍(federate and feeding and eating disorders, federate)共病的相关因素由于其内分泌和心脏代谢的并发症,需要进行精确的研究。因此,本研究旨在研究精神分裂症患者和非临床对照者中联邦精神分裂症及其相关关键因素的患病率。本横断面相关研究采用方便抽样的方法,从伊朗扎黑丹地区的人群中选取268名伊朗参与者(包括134名精神分裂症患者和134名非临床对照者)。他们使用人口统计信息表、饮食态度测试-26项目(EAT-26)和DSM-5:研究版的结构化临床访谈进行评估。本研究结果显示,近三分之一的精神分裂症患者有联邦调查局,其患病率约为非临床对照的2.5倍(32.1%对12.7%,p<0.001)。在精神分裂症患者中,回归分析的结果还显示,较高的EAT-26得分与较高水平的焦虑、抑郁、体重指数(BMI)、2型糖尿病、吸烟、疾病早期阶段、更严重的精神病症状和服用非典型抗精神病药物相关(R2=0.93, p小于0.001)。相反,EAT-26得分与性别和精神分裂症的不同阶段没有关系。临床医生需要在精神分裂症的整个过程中,特别是在其早期阶段,评估联邦调查局的风险。有必要研究焦虑、抑郁、BMI、2型糖尿病、吸烟、精神病严重程度、抗精神病药物类别等关键因素在精神分裂症患者饮食病理模型中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.20
自引率
0.00%
发文量
20
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信